Praxis Precision Medicines, Inc. (PRAX)
Last updated: 2026-10-21 14:20:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Praxis Precision Medicines, Inc. (PRAX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $264.87, with a market capitalization of $7.26B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $154.45 to $392.70. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$7.26B | |
$266.03 | |
$914.26 | |
$11.85 | |
$264.49 | |
44.50K | |
458.63K | |
-- | |
$392.70 | |
$154.45 | |
-- | |
-- |
Praxis Precision Medicines, Inc. (PRAX) Stock Price Today
Praxis Precision Medicines, Inc. (PRAX) is currently trading at $264.87 as of 2026-10-21 14:19:00, up 0.14% ($0.38) from the previous close of $264.49
During today's regular trading session, PRAX has traded between $11.85 and $914.26, with a trading volume of 44.50K shares. The current price is near the lower end of today's range.
Praxis Precision Medicines, Inc. (PRAX) 7-Day Stock Price Change
Over the past seven days, Praxis Precision Medicines, Inc. (PRAX) moved from $251.38 to $264.87, representing a gain of 5.37% ($13.49).
The stock traded between $236.80 and $271.88 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 686.25 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
PRAX 52-Week Price Position
Position in Range: 46.3%
PRAX is currently trading at $264.87, placing it 46.3% of the way from its 52-week low of $154.45 to its 52-week high of $392.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Praxis Precision Medicines, Inc. (PRAX)?
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Praxis Precision Medicines, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 10998 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Praxis Precision Medicines, Inc. (PRAX) Stock on MEXC
Eligible investors can buy real shares of Praxis Precision Medicines, Inc. (PRAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Praxis Precision Medicines, Inc. (PRAX) stock price today?
2.Is PRAX stock going up or down today?
3.What is PRAX pre-market price?
4.What is PRAX after-hours price?
5.Is PRAX stock trading now?
6.Where does PRAX sit relative to its 52-week high and low?
7.What sector is Praxis Precision Medicines, Inc. in?
8.What is Praxis Precision Medicines, Inc.'s market capitalization and where is it listed?
9.How is PRAX valued in terms of P/E ratio and EPS?
10.Does Praxis Precision Medicines, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PRAX Stock Calculator
Estimate the value between PRAX shares and USD.
PRAX Shares to USD
1.00 PRAX shares = 264.873 USD
Calculations are estimates based on the latest available price and are for reference only.



